Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Orlistat might block the body's ability to absorb thyroid medication.

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Eurycoma longifolia extract may help increase testosterone levels and reduce andropause symptoms.

Krill oil may help reduce prostate enlargement and growth.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Titagen® improves skin, hair, nail health, and reduces osteoarthritis symptoms safely.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

A male with aromatase deficiency improved bone health with estradiol treatment.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Finasteride, selenium, and vitamin E may help prevent prostate cancer.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

A patient with complete hair loss regrew all her hair using tofacitinib.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

A mix of Polygonatum sibiricum and Nelumbinis semen may ease menopause symptoms with fewer side effects.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.